Free. Unsubscribe any time.
Vir Biotechnology, Inc. (VIR)
Vir Biotechnology, Inc. filed 43 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 8 reporting owners, covering 58 transactions and 3,426,812 shares. None carries the SEC's AFF10B5ONE flag; all 43 name a plan in a footnote. 8 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-06-02, came on the same day as the one before it (2026-06-02) and reports 1 transaction against 1 in the filing before it.
- The sales it reports total 3,200 shares, 2,821 more than the 379 in the filing before it.
- Its 43 plan statements rank 129th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 2 have more plan statements on file than it and 8 have fewer.
- Its 43 filings on file run from 2025-01-08 to 2026-06-02, and state 9 plan adoption dates, from 2024-02-29 to 2025-12-19.
Trades in Vir Biotechnology, Inc. 58
- SATO VICKI L — 2025-01-08 · S · 10,960 shares
- de Verneuil Vanina — 2025-02-26 · S · 7,373 shares
- Napolitano Janet — 2025-06-02 · S · 3,200 shares
- SATO VICKI L — 2025-07-01 · S · 22,000 shares
- Eisner Mark — 2025-07-15 · S · 6,796 shares
- Eisner Mark — 2025-07-17 · S · 3,586 shares
- SATO VICKI L — 2025-08-01 · S · 22,000 shares
- SATO VICKI L — 2025-09-02 · S · 22,000 shares
- SATO VICKI L — 2025-10-01 · S · 22,000 shares
- SVF Endurance (Cayman) Ltd — 2025-10-03 · S · 450,342 shares
- SVF Endurance (Cayman) Ltd — 2025-10-06 · S · 73,955 shares
- SVF Endurance (Cayman) Ltd — 2025-10-07 · S · 72,133 shares
Adoption dates in Vir Biotechnology, Inc. 9
- 2024-02-29 — stated in 1 filing
- 2024-06-10 — stated in 1 filing
- 2024-08-05 — stated in 3 filings
- 2025-03-27 — stated in 12 filings
- 2025-05-19 — stated in 1 filing
- 2025-06-02 — stated in 1 filing
- 2025-06-27 — stated in 1 filing
- 2025-09-03 — stated in 11 filings
- 2025-12-19 — stated in 2 filings
Results prints in Vir Biotechnology, Inc. 8
- 2025-02-26
- 2025-05-07
- 2025-08-06
- 2025-11-05
- 2026-01-12
- 2026-02-23
- 2026-05-06
- 2026-08-05
Trades before a print in Vir Biotechnology, Inc. 10
- 0 days before the 2025-02-26 print — 2025-02-26 · S · de Verneuil Vanina · 7,373 shares
- 0 days before the 2025-11-05 print — 2025-11-05 · S · de Verneuil Vanina · 2,385 shares
- 0 days before the 2026-02-23 print — 2026-02-23 · S · De Backer Marianne · 19,039 shares
- 0 days before the 2026-02-23 print — 2026-02-23 · S · Eisner Mark · 2,089 shares
- 0 days before the 2026-02-23 print — 2026-02-23 · S · O'Byrne Jason · 2,089 shares
- 0 days before the 2026-02-23 print — 2026-02-23 · S · Sabatini Brent · 1,829 shares
- 0 days before the 2026-02-23 print — 2026-02-23 · S · de Verneuil Vanina · 4,445 shares
- 2 days before the 2025-11-05 print — 2025-11-03 · S · SATO VICKI L · 22,000 shares
- 5 days before the 2025-08-06 print — 2025-08-01 · S · SATO VICKI L · 22,000 shares
- 5 days before the 2026-05-06 print — 2026-05-01 · S · SATO VICKI L · 22,000 shares
- 7 days before the 2025-11-05 print — 2025-10-29 · S · SVF Endurance (Cayman) Ltd · 100 shares
- 8 days before the 2025-11-05 print — 2025-10-28 · S · SVF Endurance (Cayman) Ltd · 24,453 shares
Interval to Vir Biotechnology, Inc.’s next reported results date
How the interval and sources are counted →
- 10within 5 days
- 15within 10 days
- 0shortest, days
- 0no later print
- de Verneuil Vanina 2025-02-26 · S · 0 days before the 2025-02-26 print · EVP and General Counsel
- SATO VICKI L 2025-08-01 · S · 5 days before the 2025-08-06 print
- SVF Endurance (Cayman) Ltd 2025-10-27 · S · 9 days before the 2025-11-05 print
- SVF Endurance (Cayman) Ltd 2025-10-28 · S · 8 days before the 2025-11-05 print
- SVF Endurance (Cayman) Ltd 2025-10-29 · S · 7 days before the 2025-11-05 print
- SATO VICKI L 2025-11-03 · S · 2 days before the 2025-11-05 print
- de Verneuil Vanina 2025-11-05 · S · 0 days before the 2025-11-05 print · EVP, General Counsel, Corp Sec
- SATO VICKI L 2026-01-02 · S · 10 days before the 2026-01-12 print
- Sabatini Brent 2026-02-13 · S · 10 days before the 2026-02-23 print · SVP, Chief Accounting Officer
- De Backer Marianne 2026-02-23 · S · 0 days before the 2026-02-23 print · Chief Executive Officer
- Eisner Mark 2026-02-23 · S · 0 days before the 2026-02-23 print · EVP and Chief Medical Officer
- O'Byrne Jason 2026-02-23 · S · 0 days before the 2026-02-23 print · EVP & Chief Financial Officer
- Sabatini Brent 2026-02-23 · S · 0 days before the 2026-02-23 print · SVP, Chief Accounting Officer
- de Verneuil Vanina 2026-02-23 · S · 0 days before the 2026-02-23 print · EVP, General Counsel, Corp Sec
- SATO VICKI L 2026-05-01 · S · 5 days before the 2026-05-06 print
Adoption dates Vir Biotechnology, Inc. states
- 2024-02-29 in 1 filing
- 2024-06-10 in 1 filing
- 2024-08-05 in 3 filings
- 2025-03-27 in 12 filings
- 2025-05-19 in 1 filing
- 2025-06-02 in 1 filing
- 2025-06-27 in 1 filing
- 2025-09-03 in 11 filings
- 2025-12-19 in 2 filings
Filing text: “10b5-1 trading plan adopted by the Reporting Person on March 27, 2025”
Reported results dates on file
- 2025-02-26
- 2025-05-07
- 2025-08-06
- 2025-11-05
- 2026-01-12
- 2026-02-23
- 2026-05-06
- 2026-08-05
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.